Supplementary Video 1 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis

Supplementary Video 1 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis

<p>Supplementary Video 1</p>

-д хадгалсан:

Номзүйн дэлгэрэнгүй
Үндсэн зохиолч:	Debarati Mukherjee (15134436) (author)
Бусад зохиолчид:	Rebecca A. Previs (16918344) (author), Corinne Haines (16918347) (author), Muthana Al Abo (16918350) (author), Patrick K. Juras (15134430) (author), Kyle C. Strickland (16918353) (author), Binita Chakraborty (16918356) (author), Sandeep Artham (15086158) (author), Regina S. Whitaker (16918359) (author), Katherine Hebert (16918362) (author), Jake Fontenot (16918365) (author), Steven R. Patierno (16918368) (author), Jennifer A. Freedman (16918371) (author), Frank H. Lau (16918374) (author), Matthew E. Burow (16918377) (author), Ching-Yi Chang (15134445) (author), Donald P. McDonnell (15051446) (author)
Хэвлэсэн:	2025
Нөхцлүүд:	Cancer Tumor Biology Molecular and Cellular Biology Therapeutic Research and Development Breast Cancer Cell Signaling Protein serine-threonine kinases Drug Targets Protein kinase & phosphatase drug targets Progression, Invasion & Metastasis Metastasis Migration and invasion
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!

Ижил төстэй зүйлс

Supplementary Video 2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
-н: Debarati Mukherjee (15134436)
Хэвлэсэн: (2025)

Supplementary Video 3 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
-н: Debarati Mukherjee (15134436)
Хэвлэсэн: (2025)

Supplementary Video 4 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
-н: Debarati Mukherjee (15134436)
Хэвлэсэн: (2025)

Supplementary Movie S1 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
-н: Jesse C. Patterson (14962862)
Хэвлэсэн: (2025)

Supplementary Movie S2 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
-н: Jesse C. Patterson (14962862)
Хэвлэсэн: (2025)

Supplementary Movie S3 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
-н: Jesse C. Patterson (14962862)
Хэвлэсэн: (2025)

Supplementary Movie S4 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
-н: Jesse C. Patterson (14962862)
Хэвлэсэн: (2025)

Supplementary Movie S5 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
-н: Jesse C. Patterson (14962862)
Хэвлэсэн: (2025)

Supplementary Movie S6 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
-н: Jesse C. Patterson (14962862)
Хэвлэсэн: (2025)

Supplementary Movie S7 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
-н: Jesse C. Patterson (14962862)
Хэвлэсэн: (2025)

Supplementary Movie S8 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
-н: Jesse C. Patterson (14962862)
Хэвлэсэн: (2025)

Supplementary Movie S9 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
-н: Jesse C. Patterson (14962862)
Хэвлэсэн: (2025)

Supplementary Table S1 from Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors
-н: Clare F. Malone (14960925)
Хэвлэсэн: (2025)

Supplementary Table S2 from Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors
-н: Clare F. Malone (14960925)
Хэвлэсэн: (2025)

Supplementary Table S3 from Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors
-н: Clare F. Malone (14960925)
Хэвлэсэн: (2025)

Supplemental Data File S3 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
-н: Katie E. Hebron (15046889)
Хэвлэсэн: (2025)

Supplementary Data File S1 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
-н: Katie E. Hebron (15046889)
Хэвлэсэн: (2025)

Supplementary Data File S2 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
-н: Katie E. Hebron (15046889)
Хэвлэсэн: (2025)

Supplementary Data File S6 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
-н: Katie E. Hebron (15046889)
Хэвлэсэн: (2025)

Supplementary Data File S7 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
-н: Katie E. Hebron (15046889)
Хэвлэсэн: (2025)

Supplementary Data File S8 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
-н: Katie E. Hebron (15046889)
Хэвлэсэн: (2025)

Supplementary Data File S9 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
-н: Katie E. Hebron (15046889)
Хэвлэсэн: (2025)

Figure S1 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates
-н: Evan C. Chen (15054014)
Хэвлэсэн: (2025)

Figure S2 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates
-н: Evan C. Chen (15054014)
Хэвлэсэн: (2025)

Figure S3 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates
-н: Evan C. Chen (15054014)
Хэвлэсэн: (2025)

Figure S4 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates
-н: Evan C. Chen (15054014)
Хэвлэсэн: (2025)

Figure S5 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates
-н: Evan C. Chen (15054014)
Хэвлэсэн: (2025)

Figure S6 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates
-н: Evan C. Chen (15054014)
Хэвлэсэн: (2025)

Supplementary Dataset S1 from Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma
-н: Srivandana Akshintala (16610490)
Хэвлэсэн: (2025)

Supplementary Table S5 from Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma
-н: Srivandana Akshintala (16610490)
Хэвлэсэн: (2025)

Supplementary Figure 1 from <i>ALK</i> Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma
-н: Anne-Florence Blandin (15056366)
Хэвлэсэн: (2025)

Supplementary Figure 2 from <i>ALK</i> Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma
-н: Anne-Florence Blandin (15056366)
Хэвлэсэн: (2025)

Supplementary Figure 3 from <i>ALK</i> Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma
-н: Anne-Florence Blandin (15056366)
Хэвлэсэн: (2025)

Supplementary Figure 4 from <i>ALK</i> Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma
-н: Anne-Florence Blandin (15056366)
Хэвлэсэн: (2025)

Supplementary Figure 5 from <i>ALK</i> Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma
-н: Anne-Florence Blandin (15056366)
Хэвлэсэн: (2025)

Supplementary Figure 6 from <i>ALK</i> Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma
-н: Anne-Florence Blandin (15056366)
Хэвлэсэн: (2025)

Supplementary Tables 1-8 from <i>ALK</i> Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma
-н: Anne-Florence Blandin (15056366)
Хэвлэсэн: (2025)

Supplementary Table S1 from Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer
-н: Erwin Tomasich (15052256)
Хэвлэсэн: (2025)

Supplementary Table S2 from Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer
-н: Erwin Tomasich (15052256)
Хэвлэсэн: (2025)

Supplementary Table S3 from Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer
-н: Erwin Tomasich (15052256)
Хэвлэсэн: (2025)

Cannot write session to /tmp/vufind_sessions/sess_hue459dpq6o5toemg2bcqtpv5b